SSNC Stock Forecast & Price Target

SS&C Technologies Hldgs is viewed positively because 2Q26 showed broad-based operational strength, with adjusted revenue of $1.697 billion, adjusted EPS of $1.76, and organic growth accelerating to 7.6% year over year, ahead of expectations and guidance. Its core businesses, including GlobeOp, GIDS, and Wealth & Investment Technologies, all posted strong organic gains, while margins held at 39.5% and share repurchases of 6.4 million shares for $435 million provided additional EPS support. The outlook is further strengthened by a proven acquisition strategy spanning roughly 80 deals, including Intralinks, DST Systems, and Blue Prism, which has expanded its product set, improved scale, and enabled AI-driven cost savings.

SS&C Technologies Hldgs is viewed negatively because organic growth is already showing cracks, with Intelligent Automation & Analytics revenue declining 1.0% and Healthcare declining 3.1% year over year, while 3Q26 organic growth is expected to step down to 5.0% at the midpoint. The business is highly exposed to fluctuating client assets and trading volumes, macro-driven demand slowdowns, and shifts toward passive investing, all of which can pressure revenue, pricing, and customer retention. Its aggressive acquisition strategy, including approximately 80 acquisitions over 35 years and the $1.03B Calastone deal, adds integration risk and leverage concerns even as net leverage was 2.8 times pro forma EBITDA at the end of 2025.